{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T17:30:36Z","timestamp":1792863036830,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41433-026-04644-5","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:04:25Z","timestamp":1782029065000},"page":"2047-2053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biopsied lacrimal glands in Japanese cohort: clinical, radiologic and histopathologic analysis"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1804-9526","authenticated-orcid":false,"given":"Muhammad","family":"Abumanhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-2870","authenticated-orcid":false,"given":"Yasuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"4644_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/01676830.2012.736595","volume":"32","author":"L Teo","year":"2013","unstructured":"Teo L, Seah LL, Choo CT, Chee SP, Chee E, Looi A. A survey of the histopathology of lacrimal gland lesions in a tertiary referral centre. Orbit. 2013;32:1\u20137.","journal-title":"Orbit"},{"key":"4644_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ceo.12371","volume":"43","author":"NH Andrew","year":"2015","unstructured":"Andrew NH, McNab AA, Selva D. Review of 268 lacrimal gland biopsies in an Australian cohort. Clin Exp Ophthalmol. 2015;43:5\u201311.","journal-title":"Clin Exp Ophthalmol"},{"key":"4644_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/01676830.2017.1352608","volume":"36","author":"P Luemsamran","year":"2017","unstructured":"Luemsamran P, Rootman J, White VA, Nassiri N, Heran MKS. The role of biopsy in lacrimal gland inflammation: a clinicopathologic study. Orbit. 2017;36:411\u20138.","journal-title":"Orbit"},{"key":"4644_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3348\/kjr.2022.0233","volume":"23","author":"SR Chung","year":"2022","unstructured":"Chung SR, Kim GJ, Choi YJ, Cho KJ, Suh CH, Kim SC, et al. Clinical and radiological features of diffuse lacrimal gland enlargement: comparisons among various etiologies in 91 biopsy-confirmed patients. Korean J Radio. 2022;23:976\u201385.","journal-title":"Korean J Radio"},{"key":"4644_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/IOP.0b013e31829165ad","volume":"29","author":"DT Ginat","year":"2013","unstructured":"Ginat DT, Freitag SK, Kieff D, Grove A, Fay A, Cunnane M, et al. Radiographic patterns of orbital involvement in IgG4-related disease. Ophthalmic Plast Reconstr Surg. 2013;29:261\u20136.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"4644_CR6","unstructured":"Zeppieri M, Patel R & Patel BC. Dacryoadenitis. 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535384\/."},{"key":"4644_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.semarthrit.2019.06.018","volume":"50","author":"J Tang","year":"2020","unstructured":"Tang J, Cai S, Ye C, Dong L. Biomarkers in IgG4-related disease: a systematic review. Semin Arthritis Rheum. 2020;50:354\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"4644_CR8","doi-asserted-by":"publisher","first-page":"6103064","DOI":"10.1155\/2018\/6103064","volume":"2018","author":"AF Karim","year":"2018","unstructured":"Karim AF, Eurelings LEM, Bansie RD, van Hagen PM, van Laar JAM, Dik WA. Soluble interleukin-2 receptor: a potential marker for monitoring disease activity in IgG4-related disease. Mediators Inflamm. 2018;2018:6103064.","journal-title":"Mediators Inflamm"},{"key":"4644_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/01676830.2022.2052113","volume":"42","author":"CJ Choi","year":"2023","unstructured":"Choi CJ, Tran AQ, Anagnostopoulos AG, Zhou HW, Tse DT, Dubovy SR. A single-institution review of lacrimal gland biopsies between 1962 and 2017. Orbit. 2023;42:148\u201356.","journal-title":"Orbit"},{"key":"4644_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1755-3768.2012.02403.x","volume":"91","author":"SL von Holstein","year":"2013","unstructured":"von Holstein SL, Therkildsen MH, Prause JU, Stenman G, Siersma VD, Heegaard S. Lacrimal gland lesions in Denmark between 1974 and 2007. Acta Ophthalmol. 2013;91:349\u201354.","journal-title":"Acta Ophthalmol"},{"key":"4644_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3960\/jslrt.20048","volume":"61","author":"T Matsuo","year":"2021","unstructured":"Matsuo T, Tanaka T, Sato Y, Kataoka H, Uka M, Ennishi D, et al. Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass. J Clin Exp Hematop. 2021;61:10\u201321.","journal-title":"J Clin Exp Hematop"},{"key":"4644_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10384-024-01072-4","volume":"68","author":"M Takahira","year":"2024","unstructured":"Takahira M, Goto H, Azumi A. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2024;68:293\u2013301.","journal-title":"Jpn J Ophthalmol"},{"key":"4644_CR13","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/archopht.125.11.1575","volume":"125","author":"M Takahira","year":"2007","unstructured":"Takahira M, Kawano M, Zen Y, Minato H, Yamada K, Sugiyama K. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol. 2007;125:1575\u20138.","journal-title":"Arch Ophthalmol"},{"key":"4644_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4329\/wjr.v6.i4.106","volume":"6","author":"MN Pakdaman","year":"2014","unstructured":"Pakdaman MN, Sepahdari AR, Elkhamary SM. Orbital inflammatory disease: pictorial review and differential diagnosis. World J Radio. 2014;6:106\u201315.","journal-title":"World J Radio"},{"key":"4644_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00417-018-4197-0","volume":"257","author":"E Ishikawa","year":"2019","unstructured":"Ishikawa E, Takahashi Y, Valencia MRP, Ana-Magadia MG, Kakizaki H. Asymmetric lacrimal gland enlargement: an indicator for detection of pathological entities other than thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2019;257:405\u201311.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4644_CR16","first-page":"59","volume":"44","author":"S Konno","year":"2024","unstructured":"Konno S, Shijubo N, Suda T. Diagnostic standard 2023 and classification of disease severity for sarcoidosis in Japan. Jpn J Sarcoidosis Other Granulomatous Disord. 2024;44:59\u201363.","journal-title":"Jpn J Sarcoidosis Other Granulomatous Disord"},{"key":"4644_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jamaophthalmol.2017.1581","volume":"135","author":"I Mombaerts","year":"2017","unstructured":"Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, et al. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach. JAMA Ophthalmol. 2017;135:769\u201376.","journal-title":"JAMA Ophthalmol"},{"key":"4644_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/03009740410006439","volume":"33","author":"M Yamamoto","year":"2004","unstructured":"Yamamoto M, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz\u2019s disease. Scand J Rheumatol. 2004;33:432\u20133.","journal-title":"Scand J Rheumatol"},{"key":"4644_CR19","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460\u201371.","journal-title":"Lancet"},{"key":"4644_CR20","first-page":"104","volume":"20","author":"A Priel","year":"2018","unstructured":"Priel A, Vishnevskia-Dai V, Hochma L, Gildener-Leapman J, Ben Simon GJ, Rosner M, et al. The epidemiological, clinical and histopathological characteristics of lacrimal gland biopsies in a tertiary care center in Israel. Isr Med Assoc J. 2018;20:104\u20138.","journal-title":"Isr Med Assoc J"},{"key":"4644_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77312-x","volume":"14","author":"L He","year":"2024","unstructured":"He L, He W. Clinicopathological features of lacrimal gland biopsy lesions in 582 Chinese patients. Sci Rep. 2024;14:26514.","journal-title":"Sci Rep"},{"key":"4644_CR22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00417-019-04327-w","volume":"257","author":"C Ahn","year":"2019","unstructured":"Ahn C, Kang S, Sa HS. Clinicopathologic features of biopsied lacrimal gland masses in 95 Korean patients. Graefes Arch Clin Exp Ophthalmol. 2019;257:1527\u201333.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4644_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-023-00174-4","volume":"16","author":"P Gounder","year":"2023","unstructured":"Gounder P, Oliphant H, Juniat V, Koenig M, Selva D, Rajak SN. Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease. Thyroid Res. 2023;16:32.","journal-title":"Thyroid Res"},{"key":"4644_CR24","first-page":"29","volume":"5","author":"\u00d6 Kilickesmez","year":"2008","unstructured":"Kilickesmez \u00d6, Tasdelen N, G\u00fcrses B, Ak\u015fit Z, Cihangiroglu M, Gurmen N. Primary MALT lymphoma of lacrimal gland in association with Sj\u00f6gren syndrome: assessment with MR imaging. Yeditepe Med J. 2008;5:29\u201332.","journal-title":"Yeditepe Med J"},{"key":"4644_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.13192","volume":"168","author":"G Nocturne","year":"2015","unstructured":"Nocturne G, Mariette X. Sj\u00f6gren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168:317\u201327.","journal-title":"Br J Haematol"},{"key":"4644_CR26","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.ophtha.2008.02.004","volume":"115","author":"H Demirci","year":"2008","unstructured":"Demirci H, Shields CL, Karatza EC, Shields JA. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology. 2008;115:1626\u2013.e1\u20133.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04644-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:58:37Z","timestamp":1788350317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04644-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4644"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04644-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yasuhiro Takahashi received speaker and consultant honoraria from Amgen Inc., Chugai Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. The other authors have no financial conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors did not use generative AI and AI-assisted technologies in the writing process.","order":2,"name":"Ethics","label":"Declaration of Generative AI","group":{"name":"EthicsHeading","label":"Ethics"}}]}}